Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation - Mar 7th, 2024, 9:00 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $11.6 Million - Dec 12, 2023 3:00 PM / by Champions Oncology

Champions Oncology Announces the Addition of Brady Davis as President - Oct 17, 2023 8:30:00 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $12.6 Million - Sep 14, 2023 12:23:35 AM / by Champions Oncology

Champions Oncology Announces Remarkable Lineup of Speakers at its Translational Oncology Symposium in Boston in September 2023 -  Aug 23, 2023 11:00:58 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $13.1 Million - Jul 26, 2023 2:35:05 PM / by Champions Oncology

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development - Apr 26, 2023 11:27:08 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $12.8 Million - Mar 16, 2023 5:10:07 PM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $14.3 Million - Dec 14, 2022 12:38:59 PM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $13.7 Million - Sep 9, 2022 11:38:02 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $12.9 Million - Jul 23, 2022 6:58:54 PM / by Champions Oncology

Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics - May 31, 2022 8:33:17 AM / by Champions Oncology

Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the ‘Best in Show’ Competition at Bio-IT World Conference & Expo - May 3, 2022 8:53:10 AM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $13.2 Million - Mar 16, 2022 5:24:27 PM / by Champions Oncology

Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors - Feb 15, 2022 8:39:56 AM / by Champions Oncology

Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates - Jan 20, 2022 8:50:46 AM / by Champions Oncology

Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs - Jan 4, 2022 9:17:36 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $11.8 Million - Dec 15, 2021 8:23:52 AM / by Champions Oncology

Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Sciences Campus - Oct 20, 2021 10:23:23 AM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $11.3 Million - Sep 14, 2021 2:33:55 PM / by Champions Oncology

Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development - Jul 26, 2021 8:50:14 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $10.6 Million - Jul 23, 2021 1:22:26 PM / by Champions Oncology

Champions Oncology and BGI Americas Announce a Strategic Partnership to provide Mass Spectrometry Proteomics, Metabolomics, and multi-omic Data Analysis Solutions - Jun 15, 2021 9:15:31 AM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $10.8 Million - Mar 12, 2021 5:56:30 PM / by Champions Oncology

Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics - Jan 19, 2021 9:00:00 AM / by Champions Oncology

Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic Data and Analytics - Jan 5, 2021 8:14:49 AM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $10.1 Million - Dec 15, 2020 4:57:58 PM / by Champions Oncology

Champions Oncology Announces the Launch of Lumin Bioinformatics, Its New Oncology Data-Driven SaaS Program - Nov 17, 2020 12:36:06 PM / by Champions Oncology

Champions Oncology Expands Its Immuno-Oncology Research Offering by Launching a Unique Autologous Tumor Infiltrating Lymphocyte Ex Vivo Platform - Nov 11, 2020 3:57:55 PM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $9.5 Million - Sep 16, 2020 10:12:27 AM / by Champions Oncology

Champions Oncology Reports Quarterly Revenue of $8.8 Million - Jul 29, 2020 2:57:35 PM / by Champions Oncology

Champions Oncology Reports Record Quarterly Revenue of $9.0 Million - Mar 19, 2020 4:45:15 PM / by Champions Oncology

The Children’s Cancer Therapy Development Institute is Collaborating with Champions Oncology and Jackson Laboratory to provide RACEact/PREA Pediatric Cancer Study Plan Services - Jan 29, 2020 10:00:00 AM / by Champions Oncology